SMART EYEGLASSES ARE THE NEXT SMARTPHONE

The smart eyeglasses market is expanding rapidly, currently dominated by Meta and Apple, both of which rely on screen-based image projection. The Israeli company EyeJets, however, has developed a groundbreaking technology poised to transform the industry.Instead of projecting images onto lenses, its system is screenless and delivers visual information directly to the user's retina, enabling greater efficiency, precision, and performance.

This capability has far-reaching implications, most notably in the medical field. The retina is the only place in the human body where blood vessels can be seen directly. EyeJets technology continuously scans these vessels and monitors subtle changes, enabling early disease detection and ongoing tracking of disease progression.

"Diabetes, hypertension, glaucoma and high cholesterol levels are just some of the conditions our technology can detect and monitor," says Eyejets co-founder and CEO, Edu Strul. "The system is based on direct projection onto the retina combined with continuous blood vessel monitoring. Beyond our core patented technology — already approved in Israel and the US, with additional approvals pending — this approach requires complementary technology we developed for precise, real-time eye-tracking. Because the eyes are in constant motion, high-quality visualization is impossible without advanced tracking. Our system delivers optimal display while simultaneously providing significant medical capabilities that don't exist in today's smart glasses."

Medical Applications Strul explains how this works in practice. "Many diseases cause measurable changes in blood vessels, so continuous monitoring enables early detection and diagnosis, which allows treatment to begin before significant damage occurs. This type of ongoing tracking can also reduce the need for repeated blood tests to monitor conditions such as diabetes or hypercholesterolemia. By combining tracking technology with spectroscopy, we can identify substances within blood vessels themselves and monitor disease progression in real time."
Improving Vision in Older Patients Such monitoring could pave the way toward personalized medicine. "Our eyeglasses will generate rich, continuous data from blood vessels, allowing physicians to tailor treatments to each patient," says Strul.

These medical advantages are, however, only part of the story. EyeJets smart glasses also offer an exceptionally wide 120-degree field of vision, double the typical 60 degrees of today's smart eyeglasses, and feature a unique optical design, enabling comfortableextended wear due to battery energy saving.

The EyeJets breakthrough is generating significant market anticipation, continues Strul. "It may sound like science fiction, but it's already here. We recently signed an agreement with Sheba Medical Center to develop glasses that enhance vision for patients with AMD, a serious eye condition affecting around 200 million people worldwide. These patients, primarily older adults, often struggle to read or recognize faces because of central vision loss. With EyeJets glasses combining advanced software and AI, they'll be able to improve their vision and see better. Development is at an advanced stage, with trials set to begin in weeks. We've also partnered with the Ichilov Medical Center to create glasses for surgeons that provide 3D vision during operations."

Continuous Monitoring of Health Issues Strul founded EyeJets with Dr. Joshua Gur, the company CTO. Strul has bachelor's and master's degrees in aerospace engineering from the Technion Institute of Technology, and served in multiple command roles in the Israel Air Force, before moving into senior management in defense industries. Dr. Gur brings 40 years' experience developing multidisciplinary systems, having held optics-focused roles in Israel Aerospace Industries, , Rafael Advanced Defense Systems and Gur Optics, which he founded. The company's Chief Medical Officer, Dr. Isaac Lifshitz, is a veteran ophthalmologist and expert in intraocular optics, with decades of experience developing devices implanted in human eye.

"Our goal is to complete technology development by the end of 2026," says Strul. "It will form the basis of products that will revolutionize medicine. Just as ChatGPT transformed generic text, we aim to transform real-time diagnosis and continuous disease monitoring, making them more efficient, non-invasive and highly beneficial for both patients and doctors. Our technology will save healthcare systems time and money while helping save lives. Smart eyeglasses are the next smartphone. In a few years, most people will wear them to watch videos and access information while simultaneously monitoring their own health. Diabetic patients, for example, will receive real-time alerts for issues such as rising glucose levels."

Future Security Applications Strul emphasizes that EyeJets technology is not confined to the company's own products. "We're developing it for integration into both existing and future platforms," he explains. "This will allow companies such as Meta and Apple to adopt the technology, adding substantial value while overcoming key limitations of current devices —particularly their weight and energy consumption. By eliminating the need for a physical display, EyeJets' approach requires far less power, offers a much wider field of view, and keeps the eyeglasses lightweight and comfortable for extended use."

Roadmap Beyond its agreements with Israeli hospitals, EyeJets is in advanced discussions with several US medical centers, including one focused on developing glasses for diagnosing and continuously monitoring diabetes. "Looking ahead, our goal is to partner with leading smart-eyeglasses manufacturers to integrate our technology into their devices," says Strul. "By 2027, we expect EyeJets technology to be embedded in products from major global brands. The platform also opens the door to additional applications, such as measuring blood alcohol levels for driver monitoring and enabling retina-based security identification, given the uniqueness of each retina. We believe companies across multiple technology sectors will recognize the transformative potential of this innovation and act accordingly."

Company website >>

In collaboration with EyeJets